Study of the Effect of Ticagrelor and Clopidogrel on the Immune Response of Healthy Volunteers

Trial Profile

Study of the Effect of Ticagrelor and Clopidogrel on the Immune Response of Healthy Volunteers

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Stroke; Thrombosis; Venous thromboembolism
  • Focus Pharmacodynamics
  • Acronyms AIR Trial
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 08 May 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01846559).
    • 19 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top